IDEXX Laboratories shares are trading lower after the company reported a Q3 revenue miss and lowered its FY23 revenue guidance.
Portfolio Pulse from Benzinga Newsdesk
IDEXX Laboratories reported a Q3 revenue miss and lowered its FY23 revenue guidance, causing its shares to trade lower.
November 01, 2023 | 3:18 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
IDEXX Laboratories' shares are trading lower due to a Q3 revenue miss and a lowered FY23 revenue guidance.
IDEXX Laboratories' shares are trading lower as the company reported lower than expected Q3 revenues and also reduced its revenue forecast for FY23. This indicates a potential slowdown in the company's growth, which is negatively impacting investor sentiment and the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100